نتائج البحث - "Combined Modality Therapy adverse effects"

المصدر: Eichenauer, D A, Becker, I, Monsef, I, Chadwick, N, de Sanctis, V, Federico, M, Fortpied, C, Gianni, A M, Henry-Amar, M, Hoskin, P, Johnson, P, Luminari, S, Bellei, M, Pulsoni, A, Sydes, M R, Valagussa, P, Viviani, S, Engert, A & Franklin, J 2017, ' Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma : a systematic review and meta-analysis of randomized clinical trials ', Haematologica, vol. 102, no. 10, pp. 1748-1757 . https://doi.org/10.3324/haematol.2017.167478
Haematologica

مصطلحات موضوعية: Oncology, Hodgkin Disease/mortality, medicine.medical_specialty, medicine.medical_treatment, Article, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, medicine, Odds Ratio, Humans, Progression-free survival, Combined Modality Therapy/adverse effects, Proportional Hazards Models, Randomized Controlled Trials as Topic, Chemotherapy, Manchester Cancer Research Centre, Hodgkin Lymphoma, Proportional hazards model, business.industry, Myelodysplastic syndromes, Antineoplastic Combined Chemotherapy Protocols/adverse effects, ResearchInstitutes_Networks_Beacons/mcrc, Hazard ratio, Neoplasms, Second Primary, Odds ratio, Hematology, medicine.disease, Combined Modality Therapy, Hodgkin Disease, Neoplasms, Second Primary/etiology, Surgery, Radiation therapy, Second Primary, 030220 oncology & carcinogenesis, Follow-Up Studies, business, 030215 immunology

وصف الملف: application/pdf; text

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bee146e782c426656e9acb1b4e25ef1c
https://doi.org/10.3324/haematol.2017.167478

5

Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience

المؤلفون: Erman Öztürk, Emre Tekgündüz, Burhan Turgut, Sibel Hacioglu, Cigdem Pala, Ismail Sari, Hakan Goker, Serdal Korkmaz, Fevzi Altuntaş, Leylagül Kaynar, Mehmet Hilmi Dogu, Yahya Buyukasik, Ayşegül Tetik, Evren Ozdemir, Sinem Civriz Bozdag

المساهمون: [Tekgunduz, Emre -- Tetik, Aysegul -- Bozdag, Sinem Civriz -- Altuntas, Fevzi] Ankara Oncol Training & Res Hosp, Hematol & Stem Cell Transplantat Clin, TR-06200 Ankara, Turkey -- [Goker, Hakan -- Buyukasik, Yahya] Hacettepe Univ, Sch Med, Dept Internal Med, Div Hematol, Ankara, Turkey -- [Kaynar, Leylagul -- Pala, Cigdem] Erciyes Univ, Sch Med, Dept Internal Med, Div Hematol, Kayseri, Turkey -- [Sari, Ismail -- Dogu, Mehmet Hilmi -- Hacioglu, Sibel Kabukcu] Pamukkale Univ, Sch Med, Dept Internal Med, Div Hematol, Denizli, Turkey -- [Ozturk, Erman] Koc Univ, Sch Med, Dept Internal Med, Div Hematol, Istanbul, Turkey -- [Turgut, Burhan] Namik Kemal Univ, Sch Med, Dept Internal Med, Div Hematol, Tekirdag, Turkey -- [Korkmaz, Serdal] Cumhuriyet Univ, Sch Med, Dept Internal Med, Div Hematol, Sivas, Turkey -- [Ozdemir, Evren] Hacettepe Univ, Sch Med, Dept Internal Med, Div Oncol, Ankara, Turkey, Kaynar, Leylagul -- 0000-0002-2035-9462, Bayram, Cem -- 0000-0001-8717-4668, Kaynar, leylagul -- 0000-0002-2035-9462, Altuntas, Fevzi -- 0000-0001-6872-3780

مصطلحات موضوعية: Male, Cancer Research, cancer patient, Lymphoblastic Leukemia, medicine.medical_treatment, retrospective study, leukemia remission, Acute lymphoblastic leukemia, Gastroenterology, survival analysis, 0302 clinical medicine, Daily practice, hemic and lymphatic diseases, middle aged, Antineoplastic Combined Chemotherapy Protocols, dasatinib, cancer survival, multimodality cancer therapy, BCR-ABL, antineoplastic agent, clinical article, Philadelphia Chromosome Positive, protein kinase inhibitor, adult, Stem cell transplantation, Hematopoietic Stem Cell Transplantation, Disease Management, clinical trial, Hematology, Precursor Cell Lymphoblastic Leukemia-Lymphoma, cohort analysis, Combined Modality Therapy, humanities, aged, female, Treatment Outcome, Oncology, medical practice, 030220 oncology & carcinogenesis, Cohort, Population study, young adult, medicine.medical_specialty, overall survival, Philadelphia chromosome, methotrexate, Article, cancer chemotherapy, hematopoietic cell, 03 medical and health sciences, Internal medicine, medicine, Humans, human, procedures, Protein Kinase Inhibitors, Retrospective Studies, Chemotherapy, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Combined Modality Therapy/adverse effects/methods, Female, Hematopoietic Stem Cell Transplantation/adverse effects/methods, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/mortality/*therapy, Protein Kinase Inhibitors/administration & dosage/therapeutic use, Survival Analysis, Young Adult, business.industry, graft versus host reaction, treatment response, Philadelphia chromosome positive cell, medicine.disease, mortality, Surgery, cyclosporin, respiratory tract diseases, Transplantation, allotransplantation, multicenter study, imatinib, Allogeneic transplantation, adverse effects, business, 030215 immunology